Average Co-Inventor Count = 5.02
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (26 from 2,405 patents)
2. Merck + Co., Inc. (2 from 4,770 patents)
3. Sumitomo Dainippon Pharma Co., Ltd. (1 from 110 patents)
4. Merck Canada Inc. (1 from 40 patents)
5. Merch Sharp & Dohme Ltd (1 from 4 patents)
29 patents:
1. 10689369 - Substituted indazole compounds as RORgammaT inhibitors and uses thereof
2. 10584121 - Heteroaryl substituted benzoic acids as RORgammaT inhibitors and uses thereof
3. 10344000 - Substituted bicyclic pyrazole compounds as RORgammaT inhibitors and uses thereof
4. 10287272 - Substituted indazole compounds as RORgammaT inhibitors and uses thereof
5. 9867821 - Hexahydro-1H-4,7-methanoisoindole-1,3-dione compounds
6. 9682978 - 2,6,7 substituted purines as HDM2 inhibitors
7. 9637493 - Substituted pyrrolopyrimidines as HDM2 inhibitors
8. 9540377 - 2,6,7,8 substituted purines as HDM2 inhibitors
9. 9309199 - Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disorders
10. 9024032 - Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disorders
11. 8962611 - Substituted imidazopyridines as HDM2 inhibitors
12. 8846657 - Substituted imidazopyridines as HDM2 inhibitors
13. 8551984 - Aminopyrimidines as SYK inhibitors
14. 8541595 - Imidazoisoindole neuropeptide S receptor antagonists
15. 8410111 - Hexahydro-1H-4,7-methanoisoindole-1,3-dione compounds